Ann Mullally

Also affiliated with Stanford Medicine, Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Fedratinib in myelofibrosis”.

Fedratinib in myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019000954

N/A

0DataRank · unranked

89 citations

John Hood, Claire Harrison, Ruben A. Mesa, Ann Mullally

COVID-19 and myeloproliferative neoplasms: some considerations

Leukemia(2020)10.1038/s41375-020-01070-8

N/A

0DataRank · unranked

10 citations

Ann Mullally, Baransel Kamaz

Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN

Frontiers in Immunology(2020)10.3389/fimmu.2020.02093

N/A

0DataRank · unranked

26 citations

Ann Mullally, Jonas S. Jutzi

Busy signal: platelet-derived growth factor activation in myelofibrosis

Haematologica(2020)10.3324/haematol.2020.253708

N/A

0DataRank · unranked

4 citations

Ann Mullally, Anna E. Marneth

Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in JAK2 -mutant myeloproliferative neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.24.265058

N/A

0DataRank · unranked

4 citations

Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R. Reilly, Sachin Patel +16 more

Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms

Cell stem cell(2021)10.1016/j.stem.2021.02.001

N/A

0DataRank · unranked

210 citations

Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R. Reilly, Sachin Patel +16 more

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Blood Advances(2021)10.1182/bloodadvances.2021004856

N/A

0DataRank · unranked

64 citations

Vibe Skov, Kristen E. Stevenson, Lillian Werner, William S. Duke, Charles Laurore +27 more

Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis

Blood Advances(2021)10.1182/bloodadvances.2020002402

N/A

0DataRank · unranked

14 citations

April J. Baral, Fatima Nadat, Grace Boyd, Rachael Smyth, Hershna Patel +11 more

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Cancer Science(2021)10.1111/cas.15210

N/A

0DataRank · unranked

6 citations

Juan Luiz Coelho‐Silva, Cristina Tavares Leal, Adriana Queiroz Arantes Rocha, Thiago Mantello Bianco, Robert S. Welner +8 more

Mechanical checkpoint regulates monocyte differentiation in fibrotic niches

Nature Materials(2022)10.1038/s41563-022-01293-3

N/A

0DataRank · unranked

87 citations

Anna E. Marneth, Kwasi Adu‐Berchie, Joshua M. Grolman, Christina M. Tringides, Yutong Liu +10 more

Biology and therapeutic targeting of molecular mechanisms in MPNs

Blood(2022)10.1182/blood.2022017416

N/A

0DataRank · unranked

67 citations

Jacqueline S. Garcia, Ann Mullally, Joan How

CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response

Leukemia(2022)10.1038/s41375-022-01781-0

N/A

0DataRank · unranked

27 citations

Anna E. Marneth, María José Jiménez‐Santos, Jessica Hem, Ángel Guerra-Moreno, Benjamin Rolles +10 more

Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications

Current Hematologic Malignancy Reports(2025)10.1007/s11899-024-00749-4

N/A

0DataRank · unranked

5 citations

Merle Riedemann, Jonas S. Jutzi, Ann Mullally, Mifra Faiz